World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
15584
World Ranking
2601
National Ranking
1242

Hana Golding publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hana Golding sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 243 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hana Golding D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hana Golding sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hana Golding is affiliated with the US Food and Drug Administration in the United States. Their research primarily focuses on the field of Medicine, with a specialization in Infectious Diseases, Immunology, Animal Science and Zoology, Epidemiology, and Neurology.

The main topics covered in Golding's work include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Animal Virus Infections Studies, Viral Gastroenteritis Research and Epidemiology, Long-Term Effects of COVID-19, SARS-CoV-2 Detection and Testing, and Respiratory Viral Infections Research.

Golding has published scientific papers in several peer-reviewed venues. The most frequent publication venues are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Clinical Infectious Diseases
  • Science Translational Medicine
  • Nature

The scientist's recent papers include:

  • Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses, 2021, Nature
  • Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits, 2020, Science Translational Medicine
  • A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice, 2021, Science Translational Medicine
  • Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients, 2021, Nature Communications
  • Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19, 2023, Nature

Frequent coauthors collaborating with Hana Golding include:

  • Surender Khurana
  • Juanjie Tang
  • Gabrielle Grubbs
  • Youri Lee
  • Supriya Ravichandran

The breadth of Golding's scholarly contributions reflects a strong focus on understanding viral infections, antibody responses, and clinical outcomes related to infectious diseases, notably SARS-CoV-2 and related coronaviruses.

Best Publications

  • A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin

    James Whittle;Stephen C. Harrison;Barton F. Haynes;Hua-Xin Liao

  • Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans.

    Thomas Hagan;Mario Cortese;Nadine Rouphael;Carolyn Boudreau

  • Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection

    M Zaitseva;A Blauvelt;S Lee;C K Lapham

  • Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus

    Yvette Edghill-Smith;Hana Golding;Jody Manischewitz;Lisa R King

  • Global analyses of human immune variation reveal baseline predictors of postvaccination responses.

    John S. Tsang;Pamela L. Schwartzberg;Yuri Kotliarov;Angelique Biancotto

  • Evidence for Cell-Surface Association Between Fusin and the CD4-gp120 Complex in Human Cell Lines

    Cheryl K. Lapham;Jun Ouyang;Bhaskar Chandrasekhar;Nga Y. Nguyen

  • MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines

    Surender Khurana;Nitin Verma;Jonathan W. Yewdell;Anne Katrin Hilbert

  • Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.

    H Golding;F A Robey;F T Gates;W Linder

  • Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus

    Surender Khurana;Wanida Chearwae;Flora Castellino;Jody Manischewitz

  • Immunity and protection against Brucella abortus

    Basil Golding;Dorothy E Scott;Orit Scharf;L.-Y Huang

  • Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals.

    H Golding;G M Shearer;K Hillman;P Lucas

  • Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody

    A.G Schmidt;H Xu;A.R Khan;T O'Donnell

  • Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.

    Kevin O. Saunders;Esther Lee;Robert Parks;David R. Martinez

  • Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets.

    Surender Khurana;Amorsolo L. Suguitan;Yonaira Rivera;Cameron P. Simmons

  • Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory Disease

    Surender Khurana;Crystal L. Loving;Jody Manischewitz;Lisa R. King

  • Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits.

    Supriya Ravichandran;Elizabeth M. Coyle;Laura Klenow;Juanjie Tang

  • Subunit Recombinant Vaccine Protects against Monkeypox

    Jean-Michel Heraud;Yvette Edghill-Smith;Yvette Edghill-Smith;Victor Ayala;Irene Kalisz

  • Influenza vaccine immunology.

    Philip R. Dormitzer;Grazia Galli;Flora Castellino;Hana Golding

  • H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination

    M. Anthony Moody;Ruijun Zhang;Emmanuel B. Walter;Christopher W. Woods

  • CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection.

    M. B. Zaitseva;S. Lee;R. L. Rabin;H. L. Tiffany

Frequent Co-Authors

Surender Khurana
Surender Khurana US Food and Drug Administration
Jody Manischewitz
Jody Manischewitz US Food and Drug Administration
Dimiter S. Dimitrov
Dimiter S. Dimitrov University of Pittsburgh
Robert Blumenthal
Robert Blumenthal University of Toledo
Alan Sher
Alan Sher National Institute of Allergy and Infectious Diseases
John F. Andersen
John F. Andersen National Institutes of Health
Alfred Singer
Alfred Singer National Institutes of Health
Julio Aliberti
Julio Aliberti National Institute of Allergy and Infectious Diseases
Andrew Blauvelt
Andrew Blauvelt Veterans Health Administration
Kanta Subbarao
Kanta Subbarao University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse career paths, particularly in healthcare and research. For those interested in advancing clinical expertise, exploring an accelerated nurse practitioner program can fast-track your journey, combining rigorous academics with flexible online study options.

Many nurses consider specialization pathways, such as transitioning via an fnp to acute care certification. This allows nurse practitioners to expand their scope to handle critical and acute patient care, increasing career versatility and impact.

For those starting fresh without a nursing background but aiming to enter the healthcare sector, enrolling in online RN programs for non nurses in Florida offers foundational nursing education with the convenience of online learning.

Understanding compensation is also vital when choosing a healthcare career. Reviewing how much a DNP makes by state through how much does a dnp make helps align career goals with financial expectations, guiding informed decisions about educational investments.

Best Scientists Citing Hana Golding

Trending Scientists

Recently Published Articles